{"abstract": "Amgen, which is developing the cancer drug to treat advanced melanoma, said it was too early to say whether the drug improved survival.", "web_url": "https://www.nytimes.com/2013/03/20/business/melanoma-drug-succeeds-in-late-stage-trial.html", "snippet": "Amgen, which is developing the cancer drug to treat advanced melanoma, said it was too early to say whether the drug improved survival.", "lead_paragraph": "A cancer drug based on a tumor-killing virus has for the first time succeeded in a late-stage clinical trial, giving a lift to a technology that has long tantalized doctors and researchers. ", "source": "The New York Times", "multimedia": [], "headline": {"main": "Melanoma Drug Succeeds in Late-Stage Trial", "kicker": null, "content_kicker": null, "print_headline": "Melanoma Drug Succeeds in Late-Stage Trial", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Clinical Trials", "rank": 1, "major": "N"}, {"name": "subject", "value": "Melanomas", "rank": 2, "major": "N"}, {"name": "organizations", "value": "AMGEN INC", "rank": 3, "major": "N"}], "pub_date": "2013-03-20T02:12:57+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Andrew Pollack", "person": [{"firstname": "Andrew", "middlename": null, "lastname": "Pollack", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/a4f75af1-90b0-5013-b849-9e61f769bf65", "word_count": 532, "uri": "nyt://article/a4f75af1-90b0-5013-b849-9e61f769bf65"}